We’re delighted to share that the crowdfunding element of Occuity’s current investment round has now officially closed.

Occuity has been featured in Ingenia magazine, the Royal Academy of Engineering’s, quarterly publication showcasing inspiring engineering stories from across the UK.

We often say that Occuity is best understood in person. Not everyone gets the chance to visit us at our headquarters in Reading, so we wanted to offer a simple alternative. As part of our Republic crowdfunding campaign, we recorded a short walkthrough video of our offices to give investors and supporters a feel for where we work and how the team operates day to day. The video was filmed in a single take and shows our labs, workspaces and the environment where our technology i

As our crowdfunding round on Republic moves towards its close, we know that many of our existing and prospective investors are especially interested in the long-term opportunity of a non-invasive glucose meter. It is one of the most significant healthcare challenges of our time - and one of the most compelling commercial opportunities.  So, we wanted to take this moment to share a deeper dive into our vision for the Occuity Indigo : where the idea came from, why we believe t

Unprecedented In Vivo Retinal Imaging Achieved in Occuity’s Reading Labs

We’re excited to invite you to a very special webinar on Wednesday 3rd December 8pm Rather than delivering another standard presentation, we wanted to do something different.

Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong.Take 2 minutes to learn more: https://europe.republic.com/pages/risk-warnings As part of our ongoing investor video series showcasing the technology, products and vision behind Occuity, our latest instalment takes a closer look at the AX1 Axiometer  — the handheld, non-contact device set to transform the growing glo

Occuity PM1 used at the world-renowned Moorfields Eye Hospital by Professor Anthony Khawaja, Professor of Ophthalmology at UCL and one of the UK’s leading glaucoma specialists.

Last week our Co-founder and CEO of Occuity, Dan Daly and CCO and founding investor, Mark Jenkins, were invited to sit down with Jonathan Roy on the UK Investor Magazine Podcast to discuss Occuity’s journey, the technology behind its non-contact optical devices and the company’s vision for transforming eye-based health screening. The conversation explored everything from the origins of Occuity and its growing product portfolio to the global market opportunity, commercial prog

Today we were delighted to welcome a creative team from Renishaw  to our Reading headquarters as they filmed a case study on how Occuity is integrating their ATOM™ encoder  into our optical technology platform. The ATOM encoder plays a key role in the precision positioning and measurement capability at the heart of our devices, so it was a pleasure to showcase exactly how their technology supports our innovations. This visit follows a similar feature we filmed previously for

It was a busy and inspiring day for Occuity — welcoming Beth White from the Office for Life Sciences to our Reading HQ before heading to Lancaster House for a celebration of UK–India relations. A proud moment to reflect on how far we’ve come and the global impact our innovation can have.

Hi, I’m Robin, Co-founder and CTO at Occuity. I wanted to help you understand more about our technology platform, so I’ve made this short video to explain how it works and why it’s so central to what we do. At Occuity, everything we create is built around a single, powerful idea — that the eye can tell us an extraordinary amount about our health.Our proprietary optical platform is what makes this possible. It’s the foundation of all our devices — from the PM1 Pachymeter  to t

As Occuity opens its latest crowdfunding round on Republic Europe, we spoke with existing investor Chris Gibbs about what drew him to support the company and how he sees its potential. “I love the tech. The science nerd in me thinks it is very cool.” Chris Gibbs, Occuity Shareholder Chris works as a freelance consultant in medical device product development and has previously held roles across R&D in a range of MedTech companies, from start-ups to global businesses. He holds

At Occuity, our mission is to create elegant, non-contact optical devices that bring advanced diagnostic capabilities into everyday healthcare settings. To achieve this, we invest deeply in research and development, pioneering new approaches in optical engineering. Central to this work is our intellectual property, which protects the originality of our technology and supports our global expansion. Occuity is a very innovative company with a very talented team of engineers, an

Occuity CEO, Dr. Dan Daly joins UK Prime Minister Sir Keir Starmer on the official UK Government Trade Delegation to India

Reflections on a Proud Moment for Occuity - Attending the Royal Academy of Engineering’s annual awards - as recipients of the 2025 Colin Campbell Mitchell Award for our work on the PM1 Pachymeter,

Occuity AX1 receives a great deal of interest at ESCRS for the measurement of axial length in myopia management

We are pleased to share that Occuity  has been invited to present at the upcoming Ophthalmology Futures European Forum 2025 , taking...

Following our great success last year in Barcelona, we are pleased to announce that Occuity will again be available for meetings, this...

Occuity Partners with Paneca Technologies as Exclusive Distributor in Turkey.